Short‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
2 findings from 1 review
Long‐term all‐cause mortality · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in long‐term all‐cause mortality compared with inpatient treatment (low certainty).
1 finding from 1 review
Major bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in major bleeding compared with inpatient treatment (low certainty).
2 findings from 1 review
Minor bleeding · people with low‐risk acute pulmonary embolism
Outpatient showed no clear difference in minor bleeding compared with inpatient treatment (low certainty).
1 finding from 1 review
Recurrent PE · people with low‐risk acute pulmonary embolism
Outpatient may leads to higher recurrent PE compared with inpatient treatment (low certainty).
1 finding from 1 review
Incidence of coronary artery abnormalities · children diagnosed with Kawasaki disease
Corticosteroids probably leads to lower incidence of coronary artery abnormalities compared with no corticosteroid use (moderate certainty).
1 finding from 1 review
Incidence of any serious adverse effects attributable to the administration of corticosteroids · children diagnosed with Kawasaki disease
1 finding from 1 review
Mortality (all‐cause) · children diagnosed with Kawasaki disease
1 finding from 1 review
Duration of clinical symptoms: fever and rash (days) · children diagnosed with Kawasaki disease
1 finding from 1 review
Time for laboratory parameters to normalise: CRP, ESR (days) Duration: N/A · children diagnosed with Kawasaki disease
1 finding from 1 review
Length of hospital stay · children diagnosed with Kawasaki disease
1 finding from 1 review
Longer term (> 1 year after disease onset) coronary morbidity (non‐aneurysmal) · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent VTE · people requiring treatment for acute DVT
1 finding from 1 review
Mortality ‐ early and intermediate · people requiring treatment for chronic DVT
1 finding from 1 review
Post‐thrombotic syndrome · people requiring treatment for chronic DVT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people requiring treatment for chronic DVT
1 finding from 1 review
Recurrent VTE · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP may leads to lower recurrent VTE ‐ early, intermediate and long term compared with BMP plus placebo (low certainty).
1 finding from 1 review
Major bleeding · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in major bleeding compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in pulmonary embolism (fatal/non‐fatal) compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
Mortality ‐ intermediate and long term · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in mortality ‐ intermediate and long term compared with BMP plus placebo (moderate certainty).
1 finding from 1 review